tiprankstipranks
Sonnet BioTherapeutics reports Q1 EPS (31c) vs. ($17.62) last year
PremiumThe FlySonnet BioTherapeutics reports Q1 EPS (31c) vs. ($17.62) last year
3M ago
SONN Earnings this Week: How Will it Perform?
PremiumPre-Earnings
SONN Earnings this Week: How Will it Perform?
3M ago
Sonnet BioTherapeutics Regains Compliance, Risks Nasdaq Delisting
PremiumCompany Announcements
Sonnet BioTherapeutics Regains Compliance, Risks Nasdaq Delisting
3M ago
Sonnet BioTherapeutics sees cash runway into 3Q24
PremiumThe FlySonnet BioTherapeutics sees cash runway into 3Q24
6M ago
Sonnet prices 2.84M shares at $1.60 in underwritten public offering
PremiumThe Fly
Sonnet prices 2.84M shares at $1.60 in underwritten public offering
7M ago
Sonnet announces results of biodistribution studies using FHAB technology
PremiumThe Fly
Sonnet announces results of biodistribution studies using FHAB technology
8M ago
Sonnet BioTherapeutics announces FDA acceptance of IND for SB221 trial
PremiumThe FlySonnet BioTherapeutics announces FDA acceptance of IND for SB221 trial
9M ago
Sonnet BioTherapeutics reports Q3 EPS (13c) vs. ($1.82) last year
PremiumThe Fly
Sonnet BioTherapeutics reports Q3 EPS (13c) vs. ($1.82) last year
9M ago
Sonnet BioTherapeutics files to sell 5.15M shares of common stock for holders
PremiumThe Fly
Sonnet BioTherapeutics files to sell 5.15M shares of common stock for holders
9M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100